a."the issue of 62,500,000 QBL shares at an issue price of $0.08 per share to raise up to $5,000,000
under a public offer made pursuant to a prospectus;
b. QBL’s costs for re-compliance with Chapters 1 and 2 of the ASX listing rules of $250,000;
c. the issue of 250,000,000 shares in consideration for the Medcan acquisition at a proposed issue
value of $0.049, the price at last close of trading, resulting in a material increase to intangible as
sets and share capital;
d. the issue of 1,195,000,000 shares in consideration for the MCL acquisition, at a proposed issue
value of $0.049, the price at last close of trading, resulting in material changes to the share capital
and reserve accounts; and
e. the issue of 30,612,245 shares to HHC to complete the acquisition of MCL’s 55% interest in HHC,
at a proposed issue value of $0.049, the price at last close of trading, resulting in a material
increase to plant and equipment, intangible assets and share capital accounts.
